Acentra Health Appoints Ezmeralda Sager as Chief Transformation Officer
23 Janeiro 2025 - 11:42AM
Acentra Health, a technology and health solutions and services
company dedicated to accelerating better outcomes for its
government and commercial healthcare clients and the populations
they serve, announced it has appointed Ezmeralda Sager as Executive
Vice President and Chief Transformation Officer (CTO), effective
January 6, 2025.
In this role, Sager will spearhead enterprise-wide change
initiatives to help Acentra Health build upon its strong track
record of innovation and execution for its clients. She will
provide strategic guidance on process improvements to optimize the
development and delivery of the company’s products, solutions, and
services to its state, federal, and commercial healthcare clients.
As a member of the Executive Leadership Team, Sager will lead a
Transformation Office and work with senior leaders to drive
business process changes that strengthen the company’s
organizational effectiveness and further differentiate its
reputation as a market leader.
“Acentra Health has always been a leader in pushing the
boundaries of possibility, from delivering the first Medicaid
Enterprise System in the cloud to creating one of the first
clinical GenAI solutions to be reviewed and approved by the Centers
for Medicare and Medicaid Services (CMS),” said Todd Stottlemyer,
Acentra Health CEO. “We have made great strides in transformation,
through automation, AI, and machine learning, and Ezmeralda’s
leadership will be pivotal in accelerating our capacity to deliver
exceptional value and outcomes for our clients.”
Prior to joining Acentra Health, Sager served as Vice President
of Global Transformation at Johnson Controls, Inc., where she led
the transformation portfolio for the $27 billion annual revenue
company focused on smart, healthy, and sustainable building
solutions. She also held senior leadership roles at Booz Allen
Hamilton, overseeing enterprise strategy and transformation
initiatives, and at SAIC, where she managed the organizational
effectiveness practice. Across her 20-plus year career, Sager has
established herself as a disruptive force for change, bringing
clarity and focus to complex programs to deliver measurable
results.
“Transformation is a cornerstone for organizations striving to
achieve sustainable growth and continual advancement,” said Sager.
“As healthcare becomes increasingly complex, the ability to
innovate, streamline operations, and deliver measurable outcomes is
more critical than ever. I am pleased to join Acentra Health at
such a vital point in its growth journey and look forward to
building on the company’s success to create lasting value for our
clients and those they serve.”
Founded in 2023, Acentra Health was named by Washington Business
Journal as one of the Washington, D.C., area’s “Fastest Growing
Companies” for 2024. That same year, the Association of Corporate
Growth’s (ACG) National Capital Chapter named the company a
Corporate Growth Award winner for creating significant corporate
value in 2023.
About Acentra Health
Acentra Health combines public sector knowledge, clinical
expertise, and technological ingenuity to modernize the healthcare
experience for state, federal, and commercial partners, and their
priority populations. From designing and developing advanced
claims, encounter, and provider solutions that drive efficiency and
cost savings to delivering clinically focused service models for
care management, clinical assessments, and quality oversight,
Acentra Health is accelerating better health outcomes. Acentra
Health is backed by Carlyle (NASDAQ: CG), a global investment firm.
Learn more at acentra.com.
Media Contact:Janice MooreVice President,
Corporate Communications703-214-3552
A photo accompanying this announcement is available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/9691f2de-1e12-44ed-9f8e-aa032eff60ee
Carlyle (NASDAQ:CG)
Gráfico Histórico do Ativo
De Jan 2025 até Fev 2025
Carlyle (NASDAQ:CG)
Gráfico Histórico do Ativo
De Fev 2024 até Fev 2025